Phase 2-ready biotech developing drugs to improve radiation therapy.
Industry: Health Care
Latest Trade: $1.50 -0.10 (-6.3%)
First Day Return: +373.3%
Return from IPO: -80.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/03/2022 |
Offer Price | $8.13 |
Price Range $8.13 - $8.13 | |
Offer Shares (mm) | 1.2 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/30/2022 |
Offer Price | $8.13 |
Price Range $8.13 - $8.13 | |
Offer Shares (mm) | 1.2 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Boustead Securities |
Valuable Capital |
Company Data | |
---|---|
Headquarters | Rockville, MD, United States |
Founded | 2012 |
Employees at IPO | 5 |
Website www.shuttlepharma.com |